HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunologic Deficiency Syndromes

Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
Also Known As:
Deficiency Syndrome, Immunologic; Deficiency Syndromes, Antibody; Deficiency Syndromes, Immunologic; Immunologic Deficiency Syndrome; Immunological Deficiency Syndromes; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody; Deficiency Syndrome, Immunological; Deficiency Syndromes, Immunological; Immunological Deficiency Syndrome; Syndrome, Antibody Deficiency; Syndrome, Immunologic Deficiency; Syndrome, Immunological Deficiency; Syndromes, Antibody Deficiency; Syndromes, Immunologic Deficiency; Syndromes, Immunological Deficiency; Antibody Deficiency Syndrome
Networked: 91 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. IgA Deficiency
2. Common Variable Immunodeficiency
3. Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
4. Autoimmune Diseases (Autoimmune Disease)
5. Anemia

Experts

1. Grimbacher, Bodo: 2 articles (08/2009 - 04/2006)
2. Salzer, Ulrich: 2 articles (08/2009 - 04/2006)
3. Schlesier, Michael: 2 articles (08/2009 - 04/2006)
4. Warnatz, Klaus: 2 articles (08/2009 - 04/2006)
5. Hopp, Russell J: 1 article (04/2022)
6. Niebur, Hana B: 1 article (04/2022)
7. Adams, Lucas J: 1 article (01/2022)
8. Alter, Galit: 1 article (01/2022)
9. Altman Doss, Alexa Michelle: 1 article (01/2022)
10. Bertera, Harry L: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Immunologic Deficiency Syndromes:
1. Immunoglobulins (Immunoglobulin)IBA
2. Immunoglobulin G (IgG)IBA
3. Anti-Bacterial Agents (Antibiotics)IBA
4. Polysaccharides (Glycans)IBA
09/01/2006 - "To study the clinical and laboratory characteristics of patients with specific polysaccharide antibody deficiency syndrome. "
09/01/2006 - "Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome."
01/01/2013 - "A poor antibody response of IgM and IgA antibodies upon vaccination with pneumococcal polysaccharides (PnPS) is discussed as independent risk factors for bronchiectasis in patients with antibody deficiency syndrome (ADS) receiving immunoglobulin replacement therapy. "
05/01/1988 - "The major categories of antibody deficiency syndrome are: (1) X-linked agammaglobulinemia, involving the maturation arrest in the development of the B cells; (2) transient agammaglobulinemia, which affects both sexes is often associated with defective T helper function for immunoglobulin production; (3) acquired agammaglobulinemia, a heterogeneous disorder caused by a primary B cell defect, absence of B cells, presence of B cells but with an activation defect, failure of helper factor production by T cells or increase in suppressor cells; (4) IgG2 and IgG3 subclass deficiencies, causing significant and recurrent infections and, with IgG2, a significant impairment of the ability to respond to carbohydrate antigens such as Haemophilus influenzae, pneumococcus and meningococcus; (5) qualitative antibody deficiency syndrome in the response to carbohydrate antigens, presenting as recurrent infection and involving the inability of the patient to respond to immunization with polysaccharide antigens such as Haemophilus influenzae type b; (6) antibody deficiency states associated with T cell dysfunction. "
5. Intravenous Immunoglobulins (IVIG)FDA Link
6. gamma-Globulins (gamma-Globulin)IBA
7. AntibodiesIBA
8. Immunoglobulin M (IgM)IBA
9. Immunoglobulin A (IgA)IBA
10. Complement System Proteins (Complement)IBA

Therapies and Procedures

1. Therapeutics
2. Intravenous Administration
3. Secondary Prevention
4. Subcutaneous Infusions
5. Lung Transplantation